Home Biolipox

Biolipox

acquired
-
Developer of Inflammatory Disease Treatments
Basic
Enterprise Profile

Basic Information

Biolipox is a research-based pharmaceutical company dedicated to developing treatments for inflammatory diseases. This includes widespread conditions such as asthma, chronic obstructive pulmonary disease (COPD), rhinitis, inflammation, and rheumatic pain. The company provides its users with the latest research on Arachidonic acid. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. This is a well-established research area that has supported several medications, including aspirin, naproxen, and Singulair.
Biolipox AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2000
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Application Scenarios
Innovative Drugs